Optimization of composition of ormustine liposomal dosage form
- Авторы: Nikolaeva L.L.1, Lantsova A.V.1, Sanarova E.V.1, Polozkova A.P.1, Orlova O.L.1, Oborotova N.A.1
-
Учреждения:
- Blokhin Russian Cancer Research Center
- Выпуск: Том 11, № 5-6 (2016)
- Страницы: 371-376
- Раздел: Article
- URL: https://journals.rcsi.science/2635-1676/article/view/219412
- DOI: https://doi.org/10.1134/S1995078016030125
- ID: 219412
Цитировать
Аннотация
The improvement of the composition and technology for the preparation of the liposomal dosage form of ormustine is under consideration. Liposomes are prepared from egg lecithin, cholesterol, and PEG-2000-DSPE by the film hydration method, with 0.1% citric acid being added to the composition to stabilize the liposome dispersion. The efficiency of loading with ormustine is (60 ± 5)% and the average vesicle size is (190 ± 20) nm.
Об авторах
L. Nikolaeva
Blokhin Russian Cancer Research Center
Автор, ответственный за переписку.
Email: alima91@yandex.ru
Россия, Moscow, 115478
A. Lantsova
Blokhin Russian Cancer Research Center
Email: alima91@yandex.ru
Россия, Moscow, 115478
E. Sanarova
Blokhin Russian Cancer Research Center
Email: alima91@yandex.ru
Россия, Moscow, 115478
A. Polozkova
Blokhin Russian Cancer Research Center
Email: alima91@yandex.ru
Россия, Moscow, 115478
O. Orlova
Blokhin Russian Cancer Research Center
Email: alima91@yandex.ru
Россия, Moscow, 115478
N. Oborotova
Blokhin Russian Cancer Research Center
Email: alima91@yandex.ru
Россия, Moscow, 115478
Дополнительные файлы
